Volume 8, Issue 7

NTM Infection in CF

Editor's note:

If you’re interested in other valuable CF medical education, our CF Virtual Roundtable webcast is now available on-demand! Start the activity here: virtual.dkbmed.com

In this program, Peter Mogayzel, Jr., MD, PhD leads a case-based discussion with Patrick Flume, MD and Lisa Saiman, MD on challenges in treating lung infections. Watch as they cover the following topics:

  •          Management of patients with declining FEV1
  •          Treatment options
  •          Reinforcing adherence
  •          Working on inhaler techniques
  •          Changing inhaled antibiotics
  •          Considering a continuous, cycled, or intermittent therapy approach

Interactive monograph also available!


In this issue:

Nontuberculous mycobacteria (NTM) pulmonary infections are increasing among people with cystic fibrosis (CF). Both diagnosis and treatment are challenging: the guidelines published by the CF Foundation and the European CF Society have not been validated in people with CF. As a result, despite long treatment regimens (with associated drug-related toxicity), NTM eradication often fails.

In this Special Edition issue, Dr. Jerry Nick, Director of the Adult CF Program at National Jewish Health in Denver, analyzes some of the recently published literature describing NTM epidemiology and transmissibility, as well as the trials of new antibiotics that may be suitable for treating people with cystic fibrosis.

Also, in the audio portion of this Special Edition issue, Dr. Nick discusses some of the key findings with eCysticFibrosis Review program director Dr. Peter Mogayzel.

Learning objectives:

  • Summarize current epidemiologic studies of NTM infection among people with cystic fibrosis.
  • Discuss the risk of infection to people with CF from environmental exposure and person-to-person transmission.
  • Describe the current research into new treatment agents that may be appropriate for NTM eradication in people with CF.


Jerry Nick, MD
Jerry Nick, MD

Professor of Medicine, Pulmonary Division
Director, Colorado Adult Cystic Fibrosis Program
National Jewish Health
Denver, Colorado

Program Directors:

Peter J. Mogayzel, Jr., MD, PhD

Professor of Pediatrics
Director, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, MD

Noah Lechtzin, MD, MHA

Director, Adult Cystic Fibrosis Program
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Suzanne Sullivan, RN, BSN

Senior Clinical Nurse
The Johns Hopkins University
Baltimore, MD

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: May 7, 2019
Expiration date: May 6, 2021